Ferdinandus J, Fendler WP, Farolfi A, Washington S, et al. PSMA PET validates higher rates of metastatic disease for European Association of Urology Biochemical Recurrence Risk Groups: an international multicenter study. J Nucl Med 2021 Oct 7. pii: jnumed.121.262821. doi: 10.2967/jnumed.121.262821.
PMID: 34620731